Lunesta and Dermatitis atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis atopic is found among people who take Lunesta, especially for people who are female, 30-39 old.

The phase IV clinical study analyzes which people take Lunesta and have Dermatitis atopic. It is created by eHealthMe based on reports of 23,837 people who have side effects when taking Lunesta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 13, 2022

23,837 people reported to have side effects when taking Lunesta.
Among them, 10 people (0.04%) have Dermatitis atopic.


What is Lunesta?

Lunesta has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 25,568 Lunesta users for its effectiveness, alternative drugs and more.

What is Dermatitis atopic?

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,238 drugs and 439 conditions by eHealthMe.

Number of Lunesta and Dermatitis atopic reports submitted per year:

Could Lunesta cause Dermatitis atopic?

Gender of people who have Dermatitis atopic when taking Lunesta *:

  • female: 80 %
  • male: 20 %

Age of people who have Dermatitis atopic when taking Lunesta *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 55.56 %
  • 40-49: 11.11 %
  • 50-59: 33.33 %
  • 60+: 0.0 %

Common drugs people take besides Lunesta *:

  1. Zyprexa Zydis: 5 people, 50.00%
  2. Patanol: 5 people, 50.00%
  3. Zantac: 5 people, 50.00%
  4. Diovan: 5 people, 50.00%
  5. Medrol: 5 people, 50.00%
  6. Risperdal: 5 people, 50.00%
  7. Nexium: 5 people, 50.00%
  8. Pantosin: 5 people, 50.00%
  9. Crestor: 4 people, 40.00%
  10. Dupixent: 4 people, 40.00%

Common side effects people have besides Dermatitis atopic *:

  1. Rashes (redness): 9 people, 90.00%
  2. Visual Field Defect: 5 people, 50.00%
  3. Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 5 people, 50.00%
  4. Constipation: 5 people, 50.00%
  5. Diarrhea: 5 people, 50.00%
  6. High Blood Pressure: 5 people, 50.00%
  7. Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 5 people, 50.00%
  8. Nasopharyngitis (inflammation of the nasopharynx): 5 people, 50.00%
  9. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 50.00%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 50.00%

Common conditions people have *:

  1. Visual Field Defect: 5 people, 50.00%
  2. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 5 people, 50.00%
  3. Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 5 people, 50.00%
  4. Constipation: 5 people, 50.00%
  5. Diarrhea: 5 people, 50.00%
  6. Gastritis (inflammation of stomach): 5 people, 50.00%
  7. High Blood Pressure: 5 people, 50.00%
  8. Iron Deficiency Anaemia: 5 people, 50.00%
  9. Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 5 people, 50.00%
  10. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lunesta and have Dermatitis atopic?

Check whether Dermatitis atopic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Dermatitis atopic and when was it recovered:

Expand to all the drugs that have ingredients of eszopiclone:

Alternative drugs to, pros and cons of Lunesta:

Common Lunesta side effects:

Browse all side effects of Lunesta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dermatitis atopic treatments and more:

COVID vaccines that are related to Dermatitis atopic:

Common drugs associated with Dermatitis atopic:

All the drugs that are associated with Dermatitis atopic:

Common conditions associated with Dermatitis atopic:

All the conditions that are associated with Dermatitis atopic:

How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone (the active ingredients of Lunesta) and Lunesta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: